Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Shunichiro Ikeda

2 papers in the library · publishing 2024-2026

Papers

Effects of transcranial direct current stimulation and mindful walking on directional brain connectivity: An isolated effective coherence analysis

Clinical Neurophysiology Practice January 1, 2026 Keiichiro Nishida, Naoya Onishi, Yosuke Koshikawa et al.

Combining anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex with treadmill walking for focused mindfulness alters brain connectivity in ways that may reduce default mode network dominance and strengthen executive control. In 77 healthy participants, active tDCS reduced information flow from the posterior cingulate cortex to the rostral anterior cingulate cortex within the default mode network, while mindfulness reduced flow from the rostral anterior cingulate cortex to the medial prefrontal cortex. Active tDCS strengthened interhemispheric executive control network connectivity. The combined intervention produced hierarchical decoupling of the default mode network, suggesting potential for facilitating mindfulness engagement.

Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens

Psychiatry and Clinical Neurosciences Reports May 16, 2024 Shunichiro Ikeda, Toshihiko Kinoshita

After a period of prohibition following 1960s abuse, clinical research on psychedelics has resumed since the 1990s, revealing rapid and sustained therapeutic effects. Cannabidiol, ketamine, MDMA, and psilocybin show promise for depression and PTSD, with potential benefits for postpartum depression and PMDD. A Phase II trial enrolling 59 patients with moderate to severe MDD found that psilocybin and escitalopram both reduced depression scores at six weeks, with no significant difference in efficacy, though psilocybin improved symptoms within hours and persisted for months. Ketamine's antidepressant effects were first demonstrated in a double-blind, placebo-controlled study with seven subjects.